351 related articles for article (PubMed ID: 23443613)
21. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.
Ashman JB; Zelefsky MJ; Hunt MS; Leibel SA; Fuks Z
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):765-71. PubMed ID: 15913914
[TBL] [Abstract][Full Text] [Related]
22. A comparison of radiation treatment plans using IMRT with helical tomotherapy and 3D conformal radiotherapy for nasal natural killer/T-cell lymphoma.
Tomita N; Kodaira T; Tachibana H; Nakamura T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A
Br J Radiol; 2009 Aug; 82(981):756-63. PubMed ID: 19366734
[TBL] [Abstract][Full Text] [Related]
23. The role and strategy of IMRT in radiotherapy of pelvic tumors: Dose escalation and critical organ sparing in prostate cancer.
Liu YM; Shiau CY; Lee ML; Huang PI; Hsieh CM; Chen PH; Lin YH; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1113-23. PubMed ID: 17197126
[TBL] [Abstract][Full Text] [Related]
24. Passive proton therapy vs. IMRT planning study with focal boost for prostate cancer.
Yeo I; Nookala P; Gordon I; Schulte R; Barnes S; Ghebremedhin A; Wang N; Yang G; Ling T; Bush D; Slater J; Patyal B
Radiat Oncol; 2015 Oct; 10():213. PubMed ID: 26499318
[TBL] [Abstract][Full Text] [Related]
25. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas.
Swanson EL; Indelicato DJ; Louis D; Flampouri S; Li Z; Morris CG; Paryani N; Slopsema R
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1549-57. PubMed ID: 22270176
[TBL] [Abstract][Full Text] [Related]
26. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
Sethi A; Mohideen N; Leybovich L; Mulhall J
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
[TBL] [Abstract][Full Text] [Related]
27. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications.
Arbea L; Ramos LI; Martínez-Monge R; Moreno M; Aristu J
Radiat Oncol; 2010 Feb; 5():17. PubMed ID: 20187944
[TBL] [Abstract][Full Text] [Related]
28. Minimising contralateral breast dose in post-mastectomy intensity-modulated radiotherapy by incorporating conformal electron irradiation.
van der Laan HP; Korevaar EW; Dolsma WV; Maduro JH; Langendijk JA
Radiother Oncol; 2010 Feb; 94(2):235-40. PubMed ID: 20080312
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery.
Mansouri S; Naim A; Glaria L; Marsiglia H
Asian Pac J Cancer Prev; 2014; 15(11):4727-32. PubMed ID: 24969911
[TBL] [Abstract][Full Text] [Related]
30. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric comparison between proton beam therapy, intensity modulated radiation therapy, and 3D conformal therapy for soft tissue extremity sarcoma.
Laughlin BS; Golafshar M; Prince M; Liu W; Kutyreff CJ; Ahmed SK; Vern Gross TZ; Haddock M; Petersen I; DeWees TA; Ashman JB
Acta Oncol; 2023 May; 62(5):473-479. PubMed ID: 37154167
[TBL] [Abstract][Full Text] [Related]
32. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
34. Comparison of conventional radiotherapy and intensity-modulated radiotherapy for post-operative radiotherapy for primary extremity soft tissue sarcoma.
Stewart AJ; Lee YK; Saran FH
Radiother Oncol; 2009 Oct; 93(1):125-30. PubMed ID: 19604591
[TBL] [Abstract][Full Text] [Related]
35. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy.
Cozzi L; Dinshaw KA; Shrivastava SK; Mahantshetty U; Engineer R; Deshpande DD; Jamema SV; Vanetti E; Clivio A; Nicolini G; Fogliata A
Radiother Oncol; 2008 Nov; 89(2):180-91. PubMed ID: 18692929
[TBL] [Abstract][Full Text] [Related]
36. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
37. A novel conformal arc technique for postoperative whole pelvic radiotherapy for endometrial cancer.
Yang R; Jiang W; Wang J
Int J Gynecol Cancer; 2009 Dec; 19(9):1574-9. PubMed ID: 19955940
[TBL] [Abstract][Full Text] [Related]
38. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
39. 3D-conformal very-high energy electron therapy as candidate modality for FLASH-RT: A treatment planning study for glioblastoma and lung cancer.
Böhlen TT; Germond JF; Traneus E; Vallet V; Desorgher L; Ozsahin EM; Bochud F; Bourhis J; Moeckli R
Med Phys; 2023 Sep; 50(9):5745-5756. PubMed ID: 37427669
[TBL] [Abstract][Full Text] [Related]
40. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerations.
Fiandra C; Filippi AR; Catuzzo P; Botticella A; Ciammella P; Franco P; Borca VC; Ragona R; Tofani S; Ricardi U
Radiat Oncol; 2012 Nov; 7():186. PubMed ID: 23122028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
